AI Article Synopsis

  • The study investigates the impact of warm ischemia time (WIT) on the expression of HER2, a protein important in breast cancer diagnostics, hypothesizing that hypoxia during WIT may increase HER2 IHC scores.
  • Researchers measured HER2 mRNA levels in breast cancer cell lines and found that hypoxia increased the presence of HER2 on the cell membrane but did not affect its mRNA levels.
  • The conclusion emphasizes that while HER2 mRNA isn’t upregulated by hypoxia, the amount of HER2 protein on the membrane surfaces does increase, suggesting an important distinction in how HER2 is expressed in hypoxic conditions.

Article Abstract

Background/aim: Tissue specimen quality is becoming increasingly important for basic research and routine clinical results. Warm ischemia time (WIT) affects human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scores. However, the role of WIT on HER2 modulation remains unclear. We hypothesized that the WIT-mediated increase in HER2 IHC scores was caused by hypoxia. Therefore, this study aimed to determine the mechanism by which WIT mediates the increase in HER2.

Materials And Methods: HER2 mRNA expression was measured in 4T1, SKBR3, and HCC1954 breast cancer cell lines using real-time PCR following hypoxia exposure. The membrane proteins were isolated and extracted using the Mem-PER™ Plus Membrane Protein Extraction Kit (Thermo Fisher Scientific, Waltham, MA, USA) or evaluated through non-permeabilized immunofluorescent analysis.

Results: Hypoxic conditions up-regulated GLUT1 mRNA expression but not HER2 expression. The HER2 membrane protein fraction increased in response to hypoxic conditions. Nonpermeabilized immunofluorescence analysis showed that membrane-bound HER2 was also promoted under hypoxic conditions.

Conclusion: HER2 is not regulated at the mRNA level; however, the level of membrane-bound HER2 increases in response to hypoxia.

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.17344DOI Listing

Publication Analysis

Top Keywords

hypoxic conditions
12
her2
10
breast cancer
8
cancer cell
8
cell lines
8
ihc scores
8
mrna expression
8
membrane protein
8
expression her2
8
membrane-bound her2
8

Similar Publications

Medical Problems of Chronic Hypoxia in Highlanders Living on the Tibetan Plateau.

High Alt Med Biol

January 2025

The Research Center for High Altitude Medicine, Qinghai University, Xining, China.

Ri-Li Ge. Medical problems of chronic hypoxia in highlanders living on the tibetan plateau. 00:00-00, 2024.

View Article and Find Full Text PDF

Gastric cancer (GC) has become a major challenge in oncology research, primarily due to its detection at advanced stages. In this study, we identified and validated the pharmacological mechanisms involved in treating gastric cancer using an integrated approach combining network pharmacology, molecular docking, and a dynamic approach. Gastric cancer-related genes were obtained from DisGeNET, Genecard, and Malacard databases, while potential targets of bioactive compounds were predicted using SwissTargetPrediction.

View Article and Find Full Text PDF

Ischemic stroke is a sudden onset of neurological deficit resulting from a blockage in cerebral blood vessels, which can lead to brain tissue damage, chronic disability, and increased risk of mortality. Secretome from hypoxic mesenchymal stem cells (SH-MSC) is a potential therapy to improve neurological deficit by increasing the expression of vascular endothelial growth factor (VEGF) and reducing glial fibrillary acidic protein (GFAP). These effects can reduce the infarction area of ischemic stroke.

View Article and Find Full Text PDF

Lipid-coated oxygen microbubbles (OMBs) are being investigated for biomedical applications to alleviate hypoxia such as systemic oxygenation and image-guided radiosensitization therapy. Additionally, they hold potential for boarder application as oxygen carriers beyond the biomedical filed. Understanding the stability and oxygen release properties of OMBs in dynamic aqueous environments is critical for these applications.

View Article and Find Full Text PDF

Background: Renal ischemia-reperfusion injury (IRI) is a prevailing manifestation of acute kidney injury (AKI) with limited treatment options. TRIM44 has emerged as a possible target for treatment due to its regulatory function in inflammatory pathways.

Methods: In vivo and in vitro models were employed to ascertain the TRIM44 impact on renal IRI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!